"Hey, Yulia, where are your four bodyguards?" Hu Wenhai looked left and right, and asked suspiciously.

Yulia stroked her hair with her hand, today she actually painted some makeup, and her demeanor still exuded a faint charm. It was not the same as the last time Hu Wenhai saw her, and that kind of businesslike expression was simply incomparable.

"That's not my bodyguard. Yulia wore high heels and walked to the door of the laboratory building. Helped Hu Wenhai greet the doorman, and then pushed open the door and walked out.

"They are my relatives who have already taken Mila home with them. She explained, made a gesture of please, and let Hu Wenhai into the experimental building.

"Oh, that's right. Hu Wenhai nodded, did not continue to ask other people's private affairs, but asked the question he was interested in: "My commission was completed so quickly?

"It's not close. Yulia shook her head, as if she was a little shy that her work was not completed: "It was Mr. Andrew who called you this time, I think it is probably because the clinical trial on his side has progressed." ”

"Oh, that's right. Hu Wenhai knew that the real purpose of the little blue pill had probably been discovered by the clinic.

In Hu Wenhai's view, this is an inevitable thing, the historical Pfizer can find it, but it makes no sense that Cold Spring Port can't find it. What's more, with the immediate effect of the little blue pill, a man may not be willing to hand over this kind of medicine that greatly increases the prestige of a man.

The only question now is, what is Cold Spring Harbor's attitude?

Fortunately, this answer did not make Hu Wenhai wait too long, and Andrew received him in the living room next to his laboratory, and threw over an agreement straight to the point.

"Cold Spring Harbor Laboratory hopes to acquire the patent for sildenafil citrate in Mr. Hu's hands, I don't know what Mr. Hu wants?"

Although Cold Spring Harbor Laboratory is a non-profit organization, it is not synonymous with "poor and forced", but actually rich and handsome. The human genome sequencing project that could be done in the 80s could not be burned without hundreds of millions of dollars.

But no matter how rich Cold Spring Harbor Laboratory is, it will not dislike its own money after all. With the patent of the little blue pill in hand, whether it is to form a subsidiary or cooperate with other large pharmaceutical companies to produce it, the profits can even support the Cold Spring Harbor Laboratory to complete the human genome project on its own.

No scientist would dislike his glory too much, too much, and if it weren't for his lack of strength, Watson would not have actively promoted international cooperation in the Human Genome Project.

And now that such an opportunity to drop pie in the sky is offered by his hands, how can he be polite?

Hu Wenhai didn't look at the document on the table, because he had already made up his mind for a long time.

Although Pfizer has a long history, it can only be regarded as a first-class large-scale pharmaceutical company before the new century, and it can by no means cover the sky with one hand. Its greatest achievement was to make a lot of money selling antibiotics in World War II.

For a long time, although Pfizer has pioneered in the field of antibiotics from time to time, there is no shortage of antibiotic types in the world.

It was not until the beginning of the new century that the emergence of the little blue pill made a decisive blow to Pfizer's ascension to the pinnacle of the biological industry. From 1998 to 2009, Pfizer's market capitalization increased at least a hundredfold to more than $200 billion.

In other words, the value of this enterprise is nearly two trillion yuan. Similarly, we can look at what kind of tsunami China's $4 trillion plan threw out in the same period in China's macroeconomy -- and Pfizer, with its own value, may be able to achieve a similar effect.

And such achievements, in the final analysis, are all brought by the little blue pills. This really shocked how many people's jaws dropped, it turns out that the economy of the lower body of a man is an economic engine that can not lose to the electronics industry!

How much do you want to sell for such a patent? Hu Wenhai really wants to ask Andrew, can he afford to buy the Cold Spring Harbor Laboratory after selling all of it?

However, after all, the Cold Spring Harbor Laboratory has a reputation, and Hu Wenhai is not unwilling to give them a chance.

Hu Wenhai rested his elbows on the armrests of the sofa, crossed his hands and stroked his chin - as if he was a source of water, and said: "The Cold Spring Harbor Laboratory is willing to cooperate, of course I welcome it......

"It's not a partnership, it's an acquisition. Andrew interrupted Hu Wenhai's words in a strong voice, undoubtedly stipulating the basis of the conversation.

"It doesn't matter, it's up to you. Hu Wenhai smiled and didn't care about it, but continued: "As for my request, it is very simple, a signing fee of one billion dollars, and a patent royalty of 10% of the final price of the product. ”

The truth of the world is often not subject to human will, and Hu Wenhai also knows that the higher the voice in the negotiation, the more vulnerable the person is. And the really strong people don't like to raise their voices and threat, but whisper them, but people have to listen quietly.

As soon as Hu Wenhai's words came out, there was a sudden silence in the reception room, as if there was no sound of breathing.

Andrew was stunned for a long time, then he came back to his senses, looked at Hu Wenhai as if he had seen a ghost, and glared in surprise that was not enough to describe: "A billion dollars? Are you sure!"

Gnashing of teeth to the extent that it is as if cannibals in the Amazon jungle are preparing lunch.

"Mr. Andrew understood the misunderstanding. Hu Wenhai smiled, seeing that Andrew was obviously relieved, and then said: "This billion is only the signing fee for agreeing to the authorization, and the real patent royalty is 10% of the final price of the product." ”

"Are you crazy? Andrew didn't think about it, and after feeling that he was being tricked, he shouted in annoyance.

"Oh, then it can't be helped. Hu Wenhai shrugged his shoulders and said innocently: "I think maybe other companies will also be interested in sildenafil, after all, Cold Spring Harbor Laboratory wants to buy it." ”

"Uh-"

Andrew was just a scientist, not a professional businessman after all, and only then did he realize that his eagerness gave his opponent the initiative. But don't worry, Cold Spring Harbor Lab still has killer features available.

"Wow, I think Mr. Hu misunderstood, the Cold Spring Harbor Laboratory just thinks that this drug has value for further development. Just because we're interested in it doesn't mean it's worth a lot. ”

Andrew secretly cursed the "cunning and greedy Chinese" in his heart, and had to take the initiative to open the document, hand it to Hu Wenhai and said: "You can see that the effect of this drug in clinical trials is lackluster, and there is no advantage. Cold Spring Harbor Laboratory is willing to invest 10 million to acquire the patent of this drug, mainly because it thinks that the idea of this inhibitor is more promising, not how much your drug is really worth. ”

Obviously, the report that Andrew handed over to Hu Wenhai was in no way fake, and at least Cold Spring Harbor did not have the face to do such a thing as providing experimental false data. But to be honest, not to tell the whole truth, this is a common means in business. If someone is deceived by this, it often only ends up being a well-known success story in business school textbooks. And no one will criticize this approach, because it is just the discovery of a "market that no one else has discovered".

In this report, the clinical efficacy of sildenafil citrate on angina pectoris is indeed quite average, and there is a big gap between the effect of mainstream drugs on the market. If the price is completely set in accordance with the laws of the market, I am afraid that this kind of thing will not even be able to recover the one million US dollars paid by Hu Wenhai.

If you look at it this way, in fact, the Cold Spring Harbor Laboratory still has a conscience? The premise is that Hu Wenhai doesn't know the true value of the little blue pill, so he will think so.

"In that case, then I won't bother you at the Cold Spring Harbor Laboratory. Hu Wenhai closed the document, threw it back to Andrew, and said indispensably: "I also have a plan for continuing to develop sildenafil, and I think that since this road can be recognized by Cold Spring Port, it must have a future." In that case, hehe, I will continue to invest in it myself, and there is no need to sell the patent just like that. ”

Andrew sat down again, as if bitterly persuading, "However, I don't recommend that you do that. You must know that Cold Spring Harbor Laboratory is the world's top molecular biology laboratory, and we have the ability to carry out research and development, which may not be available to other laboratories, or it will take several times longer to complete. And IMHO, the patent law in the United States stipulates that the patent must be industrialized within three years, otherwise the patent grant will be revoked. ”

"Oh, that's not a problem. Hu Wenhai said generously: "This is the reason why I commissioned the Cold Spring Port Laboratory to develop production technology, so that I can first produce small batches and then put them on the market." ”

"So, is Mr. Hu going to sell the patent to the Cold Spring Harbor Laboratory?"

"I'm sorry. Hu Wenhai ignored Andrew's threat and said lightly: "At least 10 million dollars can't impress my attention." ”

"That's a shame......"

"yes, it's a pity, but that's business. ”

"yes, business. Andrew actually echoed Hu Wenhai with a sigh, then got up and walked to the door of the lounge next to the reception room, and pushed open the wooden door there.

"Allow me to introduce me. Andrew pointed to a white man who came out of the break room and said, "This is Baldwin, a patent attorney at Baker Law Firm in New York, who has been entrusted by Cold Spring Harbor Laboratory to be in charge of the patent dispute between Cold Spring Harbor Laboratory and your sildenafil drug." ”

"Hello, Mr. Hu from China, you can call me Baldwin, this is my business card. Baldwin wore a well-fitting black suit, hand-cut and snuggling, looking elitist.

"Oh, it seems, Cold Spring Harbor Lab isn't as pure as I thought it would be. There was no trace of surprise on Hu Wenhai's face.